J&J to acquire Ambrx Biopharma, a cancer drug developer, for $2 billion
An entrance sign to the Johnson & Johnson campus displays its logo in Irvine, California, on August 28, 2019. Marcos…
johnson and johnson
Judge certifies Johnson & Johnson shareholder class action lawsuit over talc revelations
By Reuters Published January 1, 2024 A federal judge said Johnson & Johnson shareholders can file as a class action…